Progression-free survival with fulvestrant 500 mg and alternative endocrine therapies as second-line treatment for advanced breast cancer: a network meta-analysis with parametric survival models. (Q51239075)
Jump to navigation
Jump to search
scientific article published on 26 January 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Progression-free survival with fulvestrant 500 mg and alternative endocrine therapies as second-line treatment for advanced breast cancer: a network meta-analysis with parametric survival models. |
scientific article published on 26 January 2013 |
Statements
1 reference
Progression-free survival with fulvestrant 500 mg and alternative endocrine therapies as second-line treatment for advanced breast cancer: a network meta-analysis with parametric survival models. (English)
1 reference
Shannon Cope
1 reference
Mario J N M Ouwens
1 reference
Jeroen P Jansen
1 reference
Peter Schmid
1 reference
26 January 2013
1 reference
1 reference
16
1 reference
2
1 reference
403-417
1 reference
Identifiers
1 reference